Medtronic PLC (NYSE:MDT)

109.67
Delayed Data
As of Sep 13
 -0.71 / -0.64%
Today’s Change
81.66
Today|||52-Week Range
111.24
+20.57%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
--

Company Description

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Contact Information

Medtronic Plc
20 On Hatch
Dublin Dublin 2
P:(531) 438-1700
Investor Relations:
(763) 505-2692

Employees

Shareholders

Mutual fund holders48.29%
Other institutional36.51%
Individual stakeholders0.16%

Top Executives

Omar S. IshrakChairman & Chief Executive Officer
Robert J. W. ten HoedtPresident-Europe, Middle East & Africa Region
Mark PloofSenior VP-Global Operations & Business Services
Karen L. ParkhillChief Financial & Accounting Officer, Executive VP
Richard E. KuntzChief Scientific, Clinical & Regulatory Officer